BioCryst Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-06 10:36:49 ET BCRX

Published on 05/06/2026 at 10:36 am EDT

BioCryst Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 156.41 million compared to USD 145.53 million a year ago. Net loss was USD 721.81 million compared to net income of USD 0.032 million a year ago.

Basic loss per share from continuing operations was USD 2.98. Diluted loss per share from continuing operations was USD 2.98.